Business Description
Coiled Therapeutics is a London-based medical company focused on developing new cancer treatments. Its lead drug, AO-252, targets a protein called TACC3 and is currently being tested in early human clinical trials. The company is also working on a separate program aimed at immune system conditions, which is still in laboratory testing stages.
